Currently out of the existing stock ratings of Jamie Stockton, 13 are a HOLD (46.43%), 13 are a BUY (46.43%), 2 are a SELL (7.14%).

Jamie Stockton

Work Performance Price Targets & Ratings Chart

Analyst Jamie Stockton, currently employed carries an average stock price target met ratio of 91.67% that have a potential upside of 20.82% achieved within 282 days. Previously, Jamie Stockton worked at WELLS FARGO.

Jamie Stockton’s has documented 58 price targets and ratings displayed on 9 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on IQV, IQVIA Holdings at 11-Feb-2021.

Wall Street Analyst Jamie Stockton

Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 10/29/2020. The price target of $200 was fulfilled within 1 day with a profit of $17.89 (8.21%) receiving and performance score of 82.11.

Average potential price target upside

CHNG Change Healthcare CPSI Computer Programs and Systems TDOC Teladoc BNFT Benefitfocus CERN Cerner Corp IQV IQVIA Holdings CSLT Castlight Health MDSO Medidata Solutions NXGN Nextgen Healthcare

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$27.75

2 years 2 months 1 days ago
(20-Sep-2022)

6/7 (85.71%)

$5.58 (25.17%)

151

Hold

$27.75

$0.26 (0.95%)

$26

2 years 2 months 1 days ago
(20-Sep-2022)

1/2 (50%)

$2.62 (10.43%)

125

Hold

$27.75

$0.26 (0.95%)

$18

2 years 2 months 14 days ago
(07-Sep-2022)

1/2 (50%)

$4.77 (20.76%)

534

Hold

$27.75

$0.26 (0.95%)

$26

2 years 5 months 21 days ago
(31-May-2022)

1/2 (50%)

$5.42 (24.27%)

181

Buy

$26

$-1.49 (-5.42%)

$21

2 years 10 months 18 days ago
(03-Jan-2022)

6/6 (100%)

$6.63 (34.23%)

290

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jamie Stockton?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?